qtr-three loss per share $num-one.
qtr-three adjusted loss per share $num-one excluding items.
qtr-three sales $num-one million versus refinitiv ibes estimate of $1.55 billion.
qtrly sales, excluding surcharge, were flat sequentially on num-one% lower volume.
qtrly core business was established and built upon num-one years of metallurgical expertise, manufacturing and processing experience and commitment to delivering mission-critical solutions to customers in some of the largest industries in the world.
qtr-three sg&a expenses $num-one million versus refinitiv ibes estimate of $3.0 billion.
qtrly medical end-use sales increased num-one% sequentially.
sees year-six total tax rate to be in range of num-one% to num-two% in the mid-teens.
sees qtr-four free cash flow of at least $num-one million.
qtrly sales decreased num-one% on a num-two% decrease in volume compared to qtr-three of year ago.
expect capital expenditures for fiscal year-six to be in range of $num-one million to $2.0 million, depending on timing of certain projects.
qtr-two adjusted operating loss per share $num-one.
qtr-four sales $num-one million versus refinitiv ibes estimate of $1.32 billion.
qtr-three sales $num-one million versus refinitiv ibes estimate of $3.14 billion.
expect pension expense to be lower by about $num-one million for fiscal year-six.
qtr-one operating loss per share $num-one.
